Continuum Advisory, LLC Novartis Ag Transaction History
Continuum Advisory, LLC
- $760 Million
- Q4 2024
A detailed history of Continuum Advisory, LLC transactions in Novartis Ag stock. As of the latest transaction made, Continuum Advisory, LLC holds 1,021 shares of NVS stock, worth $112,861. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,021
Previous 926
10.26%
Holding current value
$112,861
Previous $106,000
6.6%
% of portfolio
0.01%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding NVS
# of Institutions
1,492Shares Held
131MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.35 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.22 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$905 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$759 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$616 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $238B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...